InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,608.40
(
-0.01%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.87
(
-0.73%
)
Bitcoin
63,073.65
(
-0.15%
)
Post# of 45811
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Let's Roll

Send PM Follow Ignore
Followers 883
Posts 304355
Boards Moderated 5
Alias Born 06/09/2006

Let's Roll

Re: None

Friday, 09/16/2016 9:59:39 AM

Friday, September 16, 2016 9:59:39 AM

Post# of 45811
$RGBP "dCellVax is one of the programs we are developing to activate the immune system in order to allow the body to kill cancer. Immune modulation, both inhibitory and stimulatory, is unlocking many novel ways to have the human body heal itself. dCellVax is only one of our immune modulatory products that we expect to bring to market in the future. The data package we sent to the FDA is an important step in this process," said Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma.

https://finance.yahoo.com/news/regen-biopharma-inc-responds-fda-120000789.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up